12. Mai 2018 | Verschiedene
Intranasal Ketamine Succeeds for Resistant Depression in Phase 3 Trial
Intranasal Ketamine Succeeds for Resistant Depression in Phase 3 Trial
NEW YORK — Administering intranasal esketamine (Janssen) plus an antidepressant is safe, effective, and well tolerated in adult patients with treatment-resistant depressio…